Stericon Pharma Private Limited

Stericon Pharma Private Limited - home & lifestyle in Bangalore, Karnataka, India. FY 2026 financials & compliance.
CIN U33201KA1990PTC011056 Incorporated 10 July 1990 ROC Bangalore HQ Bangalore, Karnataka, India
Active Private Limited Company home and lifestyle MSME · Medium
Revenue · FY 2025
₹169.15 Cr
▲ 21% YoY
Net profit · FY 2025
₹48.24 Cr
Net margin 28.5%
EBITDA · FY 2025
₹67.94 Cr
EBITDA margin 40.2%
Authorised capital
₹4.75 Cr
Registered with MCA
Paid-up capital
₹4.37 Cr
Issued & subscribed
Satisfied charges
₹16.96 Cr
No open charges
Company age
36 yrs
Est. 1990
Employees · EPFO
222
Provident fund records

About Stericon Pharma Private Limited

Data last updated:

Stericon Pharma Private Limited is a private limited company based in Bangalore, Karnataka, India, a subsidiary of Nirma Chemical Works Private Limited. It operates in the lifestyle products and accessories manufacturing segment of the home and lifestyle products sector. It was incorporated on 10 July 1990 and has been in existence for over 36 years.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U33201KA1990PTC011056. Its GSTIN is 29AAACV6622N1ZU (Karnataka). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹4.75 Cr and a paid-up capital of ₹4.37 Cr. It was formerly known as Vista Optics (I) Pvt Ltd. It is led by directors including Amar Narendrabhai Shah and Chinmay Rajesh Vasa.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.9R Sub Layout Of Plot No.9 1st Phase Bommasandra Industrial Area, Bangalore, Karnataka, India – 560099.

As per the financials filed for FY 2025, the company reported a revenue of ₹169.15 Cr, a growth of 21% compared to the previous year. For the same year it recorded a net profit of ₹48.24 Cr (net margin 28.5%) and EBITDA of ₹67.94 Cr (EBITDA margin 40.2%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years and 15% over five years.

The company has about 222 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Stericon. As per MCA filings, the company has satisfied charges of ₹16.96 Cr on record. Court records list 3 cases involving the company, including 3 filed against it. The company has 7 deals on record (4 funding rounds, 3 secondary share transfers), with disclosed funding of ₹53.44 Cr; the latest was in March 2023. Its 5 peer companies in the Consumer Products industry (Formulations, Lifestyle and Accessories Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 2 smaller; the largest is BDR Lifesciences Private Limited with revenue of ₹176.87 Cr.

Stericon Pharma Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0000216). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website stericon.net.

Company details

CIN U33201KA1990PTC011056
Registration Number 011056
Incorporation Date 10 July 1990
ROC Bangalore
Listing Status Unlisted
Company Status Active
Parent Company Nirma Chemical Works Private Limited
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-KR-03-0000216

Recognitions & Rankings of Stericon Pharma

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-KR-03-0000216

Contact details

Stericon Pharma Private Limited's registered office is in Bangalore, Karnataka. Its website is stericon.net. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    No.9R Sub Layout Of Plot No.9 1st Phase Bommasandra Industrial Area, Bangalore, Karnataka, India – 560099
  • Industry
    Home & Lifestyle, Lifestyle Products & Accessories Manufacturing

To see the full contact details of Stericon Pharma Private Limited, buy the company report.

Comprehensive company report
Stericon Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Stericon Pharma operates one associated brand: Stericon. Each brand links to its own profile.

BrandDescriptionWebsite
Private label contact lens cleaning solutions are manufactured by Stericon.stericon.net

Business activity

The main business activities of Stericon Pharma are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Stericon Pharma Private Limited, buy the company report.

Financials of Stericon Pharma Private Limited

FY 2025 filings available

Stericon Pharma Private Limited reported revenue of ₹169.15 Cr (up 21% YoY) for FY 2025.

Revenue · FY 2025
₹169.15 Cr ▲ 21%
Net profit · FY 2025
₹48.24 Cr margin 28.5%
EBITDA · FY 2025
₹67.94 Cr margin 40.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 21%
3 years · compounded
▲ 22%
5 years · compounded
▲ 15%
EBITDA CAGR growth
1 year
▲ 30%
3 years · compounded
▲ 36%
5 years · compounded
▲ 30%

Revenue has grown at a compounded annual rate (CAGR) of 15% over five years, including 21% growth in the latest year. EBITDA rose 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹67.94 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹48.24 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin40.2%
Net Profit Margin28.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Stericon Pharma Private Limited, buy the company report.

Board of directors of Stericon Pharma Private Limited

Stericon Pharma has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Amar Narendrabhai ShahDirector28 Mar 20233 Years 7 MonthsCurrent
Chinmay Rajesh VasaDirector28 Mar 20233 Years 7 MonthsCurrent
Ajay Bhushanlal KhushuDirector03 Apr 20242 Years 7 MonthsCurrent

Peer comparison

Stericon Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Consumer Products industry (Formulations, Lifestyle and Accessories Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
BDR Lifesciences Private Limited₹176.87 Cr (FY 2025)-5.0%Vadodara, Gujarat, India
Bakson Drugs and Pharmaceuticals Private Limited₹172.81 Cr (FY 2025)15.0%New Delhi, Delhi, India
Shree Krishnakeshav Laboratories Limited₹170.52 Cr (FY 2025)13.0%Ahmedabad, Gujarat, India
Stericon Pharma Private Limitedthis company₹169.15 Cr (FY 2025)₹48.24 Cr28.5%21.0%222Bangalore, Karnataka, India
Eurolife Healthcare Private Limited₹168.9 Cr (FY 2020)-20.0%Thane, Maharashtra, India
Group Pharmaceuticals Limited₹168.31 Cr (FY 2025)10.0%Thane, Maharashtra, India

To see the full peer comparison of Stericon Pharma Private Limited, buy the company report.

Auditor

Stericon Pharma Private Limited is audited by Price Waterhouse Chartered Accountants LLP for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Price Waterhouse Chartered Accountants LLPFY 2023012754N/N500016

Shareholding

The shareholding of Stericon Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Stericon Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹16.96 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹10.49 Cr
Others₹5.92 Cr
State Bank of India₹0.55 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
02 Mar 2020100332903Hdfc Bank Limited₹10 CrSatisfied
16 Dec 2016100110804Others₹46 LakhSatisfied
03 Oct 2016100110801Hdfc Bank Limited₹49 LakhSatisfied
06 Mar 200810143647Others₹5.46 CrSatisfied
10 Sep 200480055510State Bank of India₹13.5 LakhSatisfied

To see the full charge records of Stericon Pharma Private Limited, buy the company report.

Total charge records: 6 View all charges

Deals & funding

Stericon Pharma Private Limited has 7 deals on record (4 funding rounds, 3 secondary share transfers), with disclosed funding of ₹53.44 Cr; the latest was in March 2023.

Total deals
7
Funding rounds
4
Secondary share transfers
3
Disclosed funding
₹53.44 Cr

Deals on record (5 of 7)

WhenDealAmountParties
Mar 2023Secondary share transferUndisclosedBuyer: Nirma Chemical Works Private Limited
Seller: InvAscent, 2 individuals
Mar 2016Secondary share transferUndisclosedBuyer: an individual
Seller: Silklens Private Limited , Crystal Vision Private Limited , an individual
Feb 2013Funding round₹25 LakhInvestors: 2 individuals
Mar 2011Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Mar 2008Funding round₹38.8 LakhInvestors: Silklens Private Limited , Crystal Vision Private Limited

To see the full deal history of Stericon Pharma Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Stericon Pharma Private Limited was last rated by Crisil on 19 Nov 2020.

Rating agencyRated onRating
Crisil19 Nov 2020

To see the full credit ratings and regulatory alerts of Stericon Pharma Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Stericon Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Stericon Pharma Private Limited has a workforce of 222 employees on its EPFO records as of Mar 2026, across 1 active EPFO establishment.

Employee count
222
Active EPFO establishments
1
Employee growth
11%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2025-26222
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Stericon Pharma Private Limited, buy the company report.

GST

Stericon Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
29AAACV6622N1ZUKarnatakaActive01 Jul 2017

To see the full GST registrations and return filing status of Stericon Pharma Private Limited, buy the company report.

Recent activity

Stericon Pharma Private Limited has 10 board changes on record since 2009: 3 appointments and 7 cessations. The latest: Ajay Bhushanlal Khushu ceased to be Additional Director on 08 Aug 2024.

AGM
Stericon Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Stericon Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Ceased
Ajay Bhushanlal Khushu ceased to be Additional Director.
Appointed
Ajay Bhushanlal Khushu was appointed as Director.
Ceased
Amar Narendrabhai Shah ceased to be Additional Director.
Ceased
Chinmay Rajesh Vasa ceased to be Additional Director.
Ceased
Divakar Chandran ceased to be Managing Director.
Appointed
Amar Narendrabhai Shah was appointed as Director.
Appointed
Chinmay Rajesh Vasa was appointed as Director.
Ceased
Tirunelveli Padmanabhan Devarajan ceased to be Nominee Director.
Charges
A charge registered on 02 Mar 2020 via Charge ID 100332903 with Hdfc Bank Limited was fully satisfied on 02 Mar 2023.
Charges
A charge with Hdfc Bank Limited of Rs. 10.00 Cr registered on 02 Mar 2020 with Charge ID 100332903 was modified on 03 Nov 2020.

16 earlier events are in the company report.

Frequently asked questions

Stericon Pharma is an active private limited company based in Bangalore, Karnataka, India. The company works in lifestyle products and accessories manufacturing, within the home and lifestyle industry. It was incorporated on 10 July 1990 (36+ years old) and is registered under CIN U33201KA1990PTC011056.

Stericon Pharma has 3 current directors:

The latest financial statements of Stericon Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Stericon Pharma is 29AAACV6622N1ZU, registered in Karnataka. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Stericon Pharma is U33201KA1990PTC011056. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Stericon Pharma has 3 court cases on record: 3 filed against it. Most are in the high courts.

Stericon Pharma was incorporated on 10 July 1990, making it 36+ years old. It is registered with the Registrar of Companies, Bangalore.

Stericon Pharma has 7 deals on record (4 funding rounds, 3 secondary share transfers), with disclosed funding of ₹53.44 Cr; the latest was in March 2023.

The peers of Stericon Pharma by revenue are BDR Lifesciences Private Limited, Bakson Drugs and Pharmaceuticals Private Limited, Shree Krishnakeshav Laboratories Limited, Eurolife Healthcare Private Limited, Group Pharmaceuticals Limited, all in the Consumer Products industry (Formulations, Lifestyle and Accessories Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Ajay Bhushanlal Khushu ceased to be Additional Director on 08 Aug 2024. Ajay Bhushanlal Khushu was appointed as Director on 03 Apr 2024. Amar Narendrabhai Shah ceased to be Additional Director on 29 Mar 2023. Stericon Pharma has 10 board changes on record in total.

Yes, Stericon Pharma is registered as a medium enterprise under Udyam registration (number: UDYAM-KR-03-0000216).